599 related articles for article (PubMed ID: 27806849)
1. Dermatofibrosarcoma protuberans: pathology, genetics, and potential therapeutic strategies.
Thway K; Noujaim J; Jones RL; Fisher C
Ann Diagn Pathol; 2016 Dec; 25():64-71. PubMed ID: 27806849
[TBL] [Abstract][Full Text] [Related]
2. Dermatofibrosarcoma protuberans: a comprehensive review and update on diagnosis and management.
Llombart B; Serra-Guillén C; Monteagudo C; López Guerrero JA; Sanmartín O
Semin Diagn Pathol; 2013 Feb; 30(1):13-28. PubMed ID: 23327727
[TBL] [Abstract][Full Text] [Related]
3. Dermatofibrosarcoma protuberans: from translocation to targeted therapy.
Noujaim J; Thway K; Fisher C; Jones RL
Cancer Biol Med; 2015 Dec; 12(4):375-84. PubMed ID: 26779374
[TBL] [Abstract][Full Text] [Related]
4. Dermatofibrosarcoma protuberans, version 1.2014.
Bichakjian CK; Olencki T; Alam M; Andersen JS; Berg D; Bowen GM; Cheney RT; Daniels GA; Glass LF; Grekin RC; Grossman K; Ho AL; Lewis KD; Lydiatt DD; Morrison WH; Nehal KS; Nelson KC; Nghiem P; Perlis CS; Shaha AR; Thorstad WL; Tuli M; Urist MM; Wang TS; Werchniak AE; Wong SL; Zic JA; McMillian N; Hoffman K; Ho M
J Natl Compr Canc Netw; 2014 Jun; 12(6):863-8. PubMed ID: 24925197
[TBL] [Abstract][Full Text] [Related]
5. [From cytogenetics to cytogenomics of dermatofibrosarcoma protuberans family of tumors].
Bianchini L; Maire G; Pedeutour F;
Bull Cancer; 2007 Feb; 94(2):179-89. PubMed ID: 17337387
[TBL] [Abstract][Full Text] [Related]
6. From Morphea to Dermatofibrosarcoma Protuberans.
Crnarić I; Šitum M; Delaš Aždajić M; Vučić M; Buljan M
Acta Dermatovenerol Croat; 2022 Sep; 30(2):113-115. PubMed ID: 36254545
[TBL] [Abstract][Full Text] [Related]
7. Dermatofibrosarcoma Protuberans.
Allen A; Ahn C; Sangüeza OP
Dermatol Clin; 2019 Oct; 37(4):483-488. PubMed ID: 31466588
[TBL] [Abstract][Full Text] [Related]
8. Novel TNC-PDGFD fusion in fibrosarcomatous dermatofibrosarcoma protuberans: a case report.
Chen Y; Shi YZ; Feng XH; Wang XT; He XL; Zhao M
Diagn Pathol; 2021 Jul; 16(1):63. PubMed ID: 34256767
[TBL] [Abstract][Full Text] [Related]
9. Dermatofibrosarcoma protuberans: clinical, pathological, and genetic (COL1A1-PDGFB ) study with therapeutic implications.
Llombart B; Sanmartín O; López-Guerrero JA; Monteagudo C; Serra C; Requena C; Poveda A; Vistós JL; Almenar S; Llombart-Bosch A; Guillén C
Histopathology; 2009 Jun; 54(7):860-72. PubMed ID: 19635106
[TBL] [Abstract][Full Text] [Related]
10. Application of COL1A1-PDGFB fusion gene detection by fluorescence in situ hybridization in biopsy tissue of dermatofibrosarcoma protuberans.
Zhang Z; Chen H; Chen M; He X; Wang Y; Zhang H
J Dermatol; 2017 Jul; 44(7):798-802. PubMed ID: 28150334
[TBL] [Abstract][Full Text] [Related]
11. PDGFB rearrangement in dermatofibrosarcoma protuberans: correlation with clinicopathologic characteristics and clinical implications.
Ha SY; Lee SE; Kwon MJ; Kim YJ; Lee EH; Seo J; Jang KT; Lee J; Choi YL
Hum Pathol; 2013 Jul; 44(7):1300-9. PubMed ID: 23347652
[TBL] [Abstract][Full Text] [Related]
12. Genetics of dermatofibrosarcoma protuberans family of tumors: from ring chromosomes to tyrosine kinase inhibitor treatment.
Sirvent N; Maire G; Pedeutour F
Genes Chromosomes Cancer; 2003 May; 37(1):1-19. PubMed ID: 12661001
[TBL] [Abstract][Full Text] [Related]
13. Detection of COL1A1-PDGFB fusion transcripts in dermatofibrosarcoma protuberans by reverse transcription-polymerase chain reaction using archival formalin-fixed, paraffin-embedded tissues.
Wang J; Hisaoka M; Shimajiri S; Morimitsu Y; Hashimoto H
Diagn Mol Pathol; 1999 Sep; 8(3):113-9. PubMed ID: 10565681
[TBL] [Abstract][Full Text] [Related]
14. Dermatofibrosarcoma protuberans: a clinicopathological, immunohistochemical, genetic (COL1A1-PDGFB), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumors.
Llombart B; Monteagudo C; Sanmartín O; López-Guerrero JA; Serra-Guillén C; Poveda A; Jorda E; Fernandez-Serra A; Pellín A; Guillén C; Llombart-Bosch A
J Am Acad Dermatol; 2011 Sep; 65(3):564-575. PubMed ID: 21570152
[TBL] [Abstract][Full Text] [Related]
15. [Dermatofibrosarcoma: Management].
Penel N; El Bedoui S; Robin YM; Decanter G
Bull Cancer; 2018 Nov; 105(11):1094-1101. PubMed ID: 30297237
[TBL] [Abstract][Full Text] [Related]
16. Guidelines for Diagnosis and Treatment of Cutaneous Sarcomas: Dermatofibrosarcoma Protuberans.
Llombart B; Serra C; Requena C; Alsina M; Morgado-Carrasco D; Través V; Sanmartín O
Actas Dermosifiliogr (Engl Ed); 2018 Dec; 109(10):868-877. PubMed ID: 30539729
[TBL] [Abstract][Full Text] [Related]
17. Dermatofibrosarcoma protuberans in children: an update on the diagnosis and treatment.
Kornik RI; Muchard LK; Teng JM
Pediatr Dermatol; 2012; 29(6):707-13. PubMed ID: 22780227
[TBL] [Abstract][Full Text] [Related]
18. Review of dermatofibrosarcoma protuberans.
Lim SX; Ramaiya A; Levell NJ; Venables ZC
Clin Exp Dermatol; 2023 Mar; 48(4):297-302. PubMed ID: 36630365
[TBL] [Abstract][Full Text] [Related]
19. Dermatofibrosarcoma protuberans, giant cell fibroblastoma, and hybrid lesions in children: clinicopathologic comparative analysis of 28 cases with molecular data--a study from the French Federation of Cancer Centers Sarcoma Group.
Terrier-Lacombe MJ; Guillou L; Maire G; Terrier P; Vince DR; de Saint Aubain Somerhausen N; Collin F; Pedeutour F; Coindre JM
Am J Surg Pathol; 2003 Jan; 27(1):27-39. PubMed ID: 12502925
[TBL] [Abstract][Full Text] [Related]
20. Transformed dermatofibrosarcoma protuberans: real time polymerase chain reaction detection of COL1A1-PDGFB fusion transcripts in sarcomatous areas.
Szollosi Z; Scholtz B; Egervari K; Nemes Z
J Clin Pathol; 2007 Feb; 60(2):190-4. PubMed ID: 16731589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
